Papers
11
Total Citations
187
H-Index
7
About
Geert Kazemier is a pioneering surgeon whose research has fundamentally reshaped the landscape of minimally invasive hepatopancreatobiliary (HPB) surgery. His work centers on comparing laparoscopic, robotic, and open approaches for complex pancreatic and liver resections, with a strong emphasis on clinical outcomes, cost-effectiveness, and long-term oncologic results. Kazemier led the landmark LEOPARD trial, which demonstrated that minimally invasive distal pancreatectomy reduces recovery time compared to open surgery, a finding with over 55 citations that has influenced global practice. He has also been at the forefront of the shift from laparoscopic to robotic surgery, publishing a seminal 600-case series showing the safety and feasibility of this transition. His international multicenter studies, including a pan-European propensity-matched analysis of robot-assisted versus laparoscopic pancreatoduodenectomy, have provided high-level evidence for surgical decision-making. With a portfolio of highly cited papers—including works on MEN1 patient management, cholangiocarcinoma outcomes, and healthcare cost analyses—Kazemier’s contributions are both clinically impactful and economically insightful. His research continues to guide the evolution of HPB surgery toward safer, more effective, and cost-conscious minimally invasive techniques.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4Robot-assisted spleen preserving pancreatic surgery in MEN1 patients22 citations · 2016
- 5
- 6
- 7
- 8
- 9
- 10